This invention discloses a
traditional Chinese medicine composition for treating allergic rhinitis and its application, relating to the field of allergic rhinitis treatment technology. It comprises: 12-18 parts
Astragalus membranaceus, 8-12 parts
Codonopsis pilosula, 6-10 parts medicated leaven (processed with
styrax), 5-9 parts
Lilium brownii, 5-10 parts
Platycodon grandiflorus, 4-7 parts
Prunus mume, 3-5 parts Cicadae
periostracum, 2-4 parts
Xanthium sibiricum (processed with
styrax), and 2-4 parts
Glycyrrhiza uralensis (processed with
styrax). This invention scientifically combines
Astragalus membranaceus and
Codonopsis pilosula (for invigorating qi and strengthening the exterior),
Xanthium sibiricum (processed with styrax) and Cicadae
periostracum (for dispelling wind and opening the orifices),
Lilium brownii and
Prunus mume (for astringing the lungs and nourishing the blood), medicated leaven (processed with styrax) for strengthening the
spleen and harmonizing the middle jiao, and
Platycodon grandiflorus and
Glycyrrhiza uralensis (processed with styrax) for harmonizing the various herbs. The proportions of each group can produce a synergistic effect, which can not only effectively relieve the external symptoms of allergic rhinitis such as
nasal congestion, runny
nose, sneezing, and nasal
itching, but also improve the patient's allergic constitution and enhance
immune tolerance by invigorating qi and strengthening the exterior, regulating
lung and
spleen functions, thereby reducing the recurrence rate and achieving a
therapeutic effect that addresses both the symptoms and the
root cause of allergic rhinitis.